Loading clinical trials...
Loading clinical trials...
This study evaluates the efficacy and tolerability of treatment for T-lymphoblastic lymphoma (T-LBL) according to a protocol for acute lymphoblastic leukemia. Patients receive one year of intensive cy...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Johann Wolfgang Goethe University Hospital
NCT07070219 · Acute Lymphocytic Leukemia Refractory, Lymphoma, Lymphoblastic
NCT06861530 · Adrenal Insufficiency, Leukemia, Lymphoblastic, Acute, Pediatric, and more
NCT00406757 · Leukaemia, Lymphoblastic, Acute and Lymphoma, Lymphoblastic
University Hospital, Medical Dept. II
Frankfurt
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions